Gynae BT 2017

Comparison 1 NACT followed by RT vs RT

 Significant heterogeneity among the trials  May be inappropriate to combine the trials  Trials divided in two ways:  Cycle interval (> 14 d vs ≤ 14 d)  Cisplatin dose intensity (< 25 vs ≥ 25 mg/m 2 /wk)

GUSTAVE ROUSSY

THÈME DU DIAPORAMA